Cite
Sivridis E, Buckley CH, Fox H. Type I and Type II estrogen and progesterone binding sites in endometrial carcinomas: their value in predicting survival. Int J Gynecol Cancer. 1993;3(2):80-88doi: 10.1046/j.1525-1438.1993.03020080.x.
Sivridis, E., Buckley, C. H., & Fox, H. (1993). Type I and Type II estrogen and progesterone binding sites in endometrial carcinomas: their value in predicting survival. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 3(2), 80-88. https://doi.org/10.1046/j.1525-1438.1993.03020080.x
Sivridis, E., et al. "Type I and Type II estrogen and progesterone binding sites in endometrial carcinomas: their value in predicting survival." International journal of gynecological cancer : official journal of the International Gynecological Cancer Society vol. 3,2 (1993): 80-88. doi: https://doi.org/10.1046/j.1525-1438.1993.03020080.x
Sivridis E, Buckley CH, Fox H. Type I and Type II estrogen and progesterone binding sites in endometrial carcinomas: their value in predicting survival. Int J Gynecol Cancer. 1993 Mar;3(2):80-88. doi: 10.1046/j.1525-1438.1993.03020080.x. PMID: 11578326.
Copy
Download .nbib